Atlas Trials

Dynavax Technologies Corporation

25 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Dynavax Technologies Corporation

RecordFirmDate
Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of Age (NCT07207408)Dynavax Technologies Corporation2025-09-11
Safety and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adults 50 Years of Age and Over (NCT06569823)Dynavax Technologies Corporation2024-06-17
Trial of the Immunogenicity, Safety, and Tolerability of rF1V Vaccine With CpG 1018® Adjuvant Compared With rF1V Vaccine in Adults 18 to 55 Years of Age (NCT05506969)Dynavax Technologies Corporation2022-08-09
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of an Investigational Herpes Zoster Vaccine (Z-1018) Compared to Shingrix® in Healthy Adult Volunteers (NCT05245838)Dynavax Technologies Corporation2022-01-10
HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis (NCT03934736)Dynavax Technologies Corporation2019-04-22
Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC (NCT03326752)Dynavax Technologies Corporation2017-09-20

Track Dynavax Technologies Corporation automatically

Every clearance here is in the API, with alerts when new ones post.